Cyclerion Therapeutics, Inc.

CYCN - CIK 0001755237

Market cap-

Rank-

SEC filings344

CYCN income statement (quarterly)

The table below shows Cyclerion Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	$0.00	$875.00K	$93.00K	$81.00K	$194.00K	$0.00
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$730.00K	$348.00K	$56.00K	$36.00K	$81.00K	$105.00K
SG&A

CYCN annual revenue (10-K history)

Cyclerion Therapeutics, Inc. reported annual revenue of $2.07M for fiscal year 2025. That is up 3.7% from $2.00M in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $4.51M (FY 2019) to $2.07M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.